Pembrolizumab: promising response rate in pretreated metastatic gastric cancer
LUGANO-MADRID, 8 September, 2017 - Pembrolizumab has shown a promising response rate in patients with pretreated metastatic gastric cancer, according to late-breaking results from the...








